ADVANCED NEUROENDOCRINE CARCINOMAS OF THE DIGESTIVE SYSTEM

Clinical trials for ADVANCED NEUROENDOCRINE CARCINOMAS OF THE DIGESTIVE SYSTEM explained in plain language.

Never miss a new study

Get alerted when new ADVANCED NEUROENDOCRINE CARCINOMAS OF THE DIGESTIVE SYSTEM trials appear

Sign up with your email to follow new studies for ADVANCED NEUROENDOCRINE CARCINOMAS OF THE DIGESTIVE SYSTEM, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New immune drug trial offers hope for Tough-to-Treat digestive cancers

Disease control Recruiting now

This study is testing a new immunotherapy drug called tarlatamab for people with advanced neuroendocrine cancer of the digestive system. The goal is to see if the drug, given alone or with standard chemotherapy, can help patients live longer by activating their own immune system …

Matched conditions: ADVANCED NEUROENDOCRINE CARCINOMAS OF THE DIGESTIVE SYSTEM

Phase: PHASE2 • Sponsor: Grupo Espanol de Tumores Neuroendocrinos • Aim: Disease control

Last updated Apr 04, 2026 10:05 UTC

ADVANCED NEUROENDOCRINE CARCINOMAS OF THE DIGESTIVE SYSTEM

Get alerted when new ADVANCED NEUROENDOCRINE CARCINOMAS OF THE DIGESTIVE SYSTEM trials appear

New immune drug trial offers hope for Tough-to-Treat digestive cancers